Hongwei Ji, MD; Andy Kim, BA; Joseph E. Ebinger, MD; et al.
free access
has audio
JAMA Cardiol. 2020;5(3):255-262. doi:10.1001/jamacardio.2019.5306
This study evaluates whether longitudinal patterns of blood pressure elevation differ between women and men during the life course when considering baseline blood pressure levels as the reference.
-
Podcast:
Sex Differences in Blood Pressure Trajectories Over the Life Course
-
Editorial
Adverse Cardiovascular Outcomes for Women鈥擝iology, Bias, or Both?
Nanette K. Wenger, MD, MACC, MACP
JAMA Cardiol
-
Podcast:
Sex Differences in Blood Pressure Trajectories Over the Life Course
Venkatesh L. Murthy, MD, PhD; Rui Xia, PhD; Abigail S. Baldridge, MS; et al.
free access
JAMA Cardiol. 2020;5(3):263-271. doi:10.1001/jamacardio.2019.5220
This cohort study quantifies the relative importance of a polygenic risk score, fitness, activity, parental history of overweight, and body mass index in young adulthood regarding body mass index trends over 25 years.
Eric Van Belle, MD, PhD; Alessandro Cosenza, MD; Sergio Bravo Baptista, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(3):272-281. doi:10.1001/jamacardio.2019.5097
This cross-sectional study evaluates the association of major adverse cardiac events (MACE) integrated with fractional flow reserve as the management strategy for diabetes with outcomes in patients with ambiguous lesions who undergo angiography.
Alexander R. van Rosendael, MD; Jagat Narula, MD, PhD; Fay Y. Lin, MD; et al.
free access
JAMA Cardiol. 2020;5(3):282-290. doi:10.1001/jamacardio.2019.5315
This case-control cohort study analyzes patients with suspected coronary atherosclerosis and control patients to identify the factors associated with higher or lower risks for adverse cardiovascular events and acute coronary syndrome.
-
Invited Commentary
The Importance of Coronary Artery Calcium Density
Michael H. Criqui, MD, MPH; Nketi I. Forbang, MD, MPH; Isac C. Thomas, MD, MPH
JAMA Cardiol
Marc D. Samsky, MD; Li Lin, MS; Stephen J. Greene, MD; et al.
free access
JAMA Cardiol. 2020;5(3):292-299. doi:10.1001/jamacardio.2019.4987
This study surveyed patients with chronic heart failure to better understand their experiences and perceptions of living with heart failure, including their familiarity and concerns with important guideline-directed medical therapies.
Ewa Piotrowicz, MD, PhD; Michael J. Pencina, PhD; Grzegorz Opolski, MD, PhD; et al.
free access
JAMA Cardiol. 2020;5(3):300-308. doi:10.1001/jamacardio.2019.5006
This randomized clinical trial assesses whether potential improvements in function and quality-of-life outcomes occur after a 9-week program of hybrid, comprehensive telerehabilitation vs usual care in patients with heart failure.
Anthony F. Yu, MD; Jessica R. Flynn, BS; Chaya S. Moskowitz, PhD; et al.
free access
JAMA Cardiol. 2020;5(3):309-317. doi:10.1001/jamacardio.2019.5586
This cross-sectional study assesses whether treatment-induced cardiotoxicity is associated with long-term cardiopulmonary dysfunction in survivors of ERBB2-positive breast cancer.
Olujimi A. Ajijola, MD, PhD; Neal A. Chatterjee, MD; Matthew J. Gonzales, MD; et al.
open access
JAMA Cardiol. 2020;5(3):318-325. doi:10.1001/jamacardio.2019.4717
This cohort study examines whether myocardial neuropeptide Y levels in coronary sinus blood samples are associated with outcomes in patients with stable chronic heart failure.
Joris Nas, MD; Jos Thannhauser, MSc; Priya Vart, PhD; et al.
free access
JAMA Cardiol. 2020;5(3):328-335. doi:10.1001/jamacardio.2019.4992
This randomized noninferiority trial compares the effect of virtual reality vs face-to-face cardiopulmonary resuscitation (CPR) training on CPR quality measured by chest compression depth and rate on CPR manikins.